Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: Case report and discussion regarding need of routine prophylaxis

Pediatric Transplantation

Volumn 10, Issue 7, 2006, Pages 826-829

  Blanchard, Samra S ^a   Gerrek, Marla ^a   Siegel, C ^a   Czinn, Steven J ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Liver transplantation; Palivizumab; Respiratory syncytial virus infection

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PALIVIZUMAB; PREDNISONE; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; TACROLIMUS;

AGE; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LIVER TRANSPLANTATION; MORBIDITY; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; MORBIDITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 33749561630     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00583.x     Document Type: Article

References (12)

1. POHL C, GREEN M, WALD ER, LEDESMA-MEDINA J. Respiratory syncytial virus infections in pediatric liver transplant recipients. J Infect Dis 1992: 165: 166-169.
2. OGRA PL, PATEL J. Respiratory syncytial virus infection and the immunocompromised host. Pediatr Infect Dis J 1988: 7: 245-249.
3. ISON MG, HAYDEN FG. Viral infections in immunocompromised patients: What's new with respiratory viruses? Curr Opin Infect Dis 2002: 15: 355-367.
4. ISON MG. Respiratory viral infections in transplant recipients. Curr Opin Organ Transplant 2005: 10: 312-319.
5. ENGLUND JA, PIEDRA PA, JEWELL A, et al. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol 1996: 34: 1649-1653.
6. VAN ELDEN LJ, VAN LOON AM, VAN DER BEEK A, et al. Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults. J Clin Microbiol 2003: 41: 4378-4381.
7. VAN ELDEN LJ, VAN KRAAIJ MG, NIJHIUS M, et al. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematologic cancer and pneumonia. Clin Infect Dis 2002: 34: 177-183.
8. HALL CB, POWELL KR, MACDONALD NE, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986: 315: 77-81.
9. BASS A, CHEIFETZ I. Respiratory syncitial virus infection after a living related transplant. Crit Care Med 2004: 32 (Suppl.12): A185.
10. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998: 102: 531-537.
11. Community-acquired respiratory viruses. Am J Transplant 2004: 4 (Suppl.10): 105-109.
12. BOECKH M, BERREY MM, BOWDEN RA, CRAWFORD SW, BALSLEY J, COREY L. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis 2001: 184: 350-354.